{"id":"https://openalex.org/W2012749031","doi":"https://doi.org/10.1002/ddr.430220207","title":"Comparative study of central and peripheral histamine\u2010H1 receptor binding in vitro and ex vivo of non\u2010sedating antihistamines and of noberastine, a new agent","display_name":"Comparative study of central and peripheral histamine\u2010H1 receptor binding in vitro and ex vivo of non\u2010sedating antihistamines and of noberastine, a new agent","publication_year":1991,"publication_date":"1991-01-01","ids":{"openalex":"https://openalex.org/W2012749031","doi":"https://doi.org/10.1002/ddr.430220207","mag":"2012749031"},"language":"en","primary_location":{"id":"doi:10.1002/ddr.430220207","doi":"https://doi.org/10.1002/ddr.430220207","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.430220207","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111527585","display_name":"Jos\u00e9e E. Leysen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Jos\u00e9e E. Leysen","raw_affiliation_strings":["Department of Biochemical Pharmacology, Janssen Research Foundation, B-2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Pharmacology, Janssen Research Foundation, B-2340 Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085926729","display_name":"W Gommeren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Walter Gommeren","raw_affiliation_strings":["Department of Biochemical Pharmacology, Janssen Research Foundation, B-2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Pharmacology, Janssen Research Foundation, B-2340 Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111705096","display_name":"Paul F.M. Janssen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Paul F. M. Janssen","raw_affiliation_strings":["Department of Biochemical Pharmacology, Janssen Research Foundation, B-2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Pharmacology, Janssen Research Foundation, B-2340 Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103427054","display_name":"Paul A. J. Janssen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Paul A. J. Janssen","raw_affiliation_strings":["Department of Biochemical Pharmacology, Janssen Research Foundation, B-2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Pharmacology, Janssen Research Foundation, B-2340 Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111527585"],"corresponding_institution_ids":["https://openalex.org/I137982388"],"apc_list":{"value":3980,"currency":"USD","value_usd":3980},"apc_paid":null,"fwci":1.2772,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.80134081,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"22","issue":"2","first_page":"165","last_page":"178"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histamine-h1-receptor","display_name":"histamine H1 receptor","score":0.8569999933242798},{"id":"https://openalex.org/keywords/second-generation-antihistamines","display_name":"second-generation antihistamines","score":0.9610000252723694},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.8090000152587891},{"id":"https://openalex.org/keywords/receptor-dissociation-kinetics","display_name":"receptor dissociation kinetics","score":0.75},{"id":"https://openalex.org/keywords/receptor-occupancy","display_name":"receptor occupancy","score":0.7570000290870667},{"id":"https://openalex.org/keywords/cerebellum","display_name":"cerebellum","score":0.8019999861717224},{"id":"https://openalex.org/keywords/lung","display_name":"lung","score":0.9269999861717224},{"id":"https://openalex.org/keywords/astemizole","display_name":"astemizole","score":0.9340000152587891},{"id":"https://openalex.org/keywords/mequitazine","display_name":"mequitazine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/terfenadine","display_name":"terfenadine","score":1.0},{"id":"https://openalex.org/keywords/loratadine","display_name":"loratadine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/cetirizine","display_name":"cetirizine","score":1.0},{"id":"https://openalex.org/keywords/guinea-pig","display_name":"guinea pig","score":0.6620000004768372},{"id":"https://openalex.org/keywords/duration-of-drug-action","display_name":"duration of drug action","score":0.5080000162124634},{"id":"https://openalex.org/keywords/neurotransmitter-inhibition","display_name":"neurotransmitter inhibition","score":0.45899999141693115}],"concepts":[{"id":"https://openalex.org/C2776129107","wikidata":"https://www.wikidata.org/wiki/Q423437","display_name":"Astemizole","level":2,"score":0.9205526113510132},{"id":"https://openalex.org/C2779303165","wikidata":"https://www.wikidata.org/wiki/Q417909","display_name":"Terfenadine","level":2,"score":0.9107739925384521},{"id":"https://openalex.org/C10335311","wikidata":"https://www.wikidata.org/wiki/Q309513","display_name":"Histamine H1 receptor","level":4,"score":0.7927175760269165},{"id":"https://openalex.org/C1122143","wikidata":"https://www.wikidata.org/wiki/Q61233","display_name":"Histamine","level":2,"score":0.7194018959999084},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7056711316108704},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6804764866828918},{"id":"https://openalex.org/C2779463773","wikidata":"https://www.wikidata.org/wiki/Q423075","display_name":"Cetirizine","level":2,"score":0.6412297487258911},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.5614909529685974},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5593791007995605},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.534572422504425},{"id":"https://openalex.org/C159545944","wikidata":"https://www.wikidata.org/wiki/Q424228","display_name":"Histamine receptor","level":4,"score":0.5000462532043457},{"id":"https://openalex.org/C74998103","wikidata":"https://www.wikidata.org/wiki/Q898254","display_name":"Dissociation constant","level":3,"score":0.49048349261283875},{"id":"https://openalex.org/C2909530563","wikidata":"https://www.wikidata.org/wiki/Q1328275","display_name":"Histamine H1 Antagonists","level":3,"score":0.42631858587265015},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.39498651027679443},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.27716127038002014},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25064098834991455},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19569239020347595},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1507333219051361},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/ddr.430220207","doi":"https://doi.org/10.1002/ddr.430220207","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.430220207","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W203823248","https://openalex.org/W205962884","https://openalex.org/W1759177440","https://openalex.org/W1809659791","https://openalex.org/W1833805811","https://openalex.org/W1976601877","https://openalex.org/W1984029445","https://openalex.org/W2013182380","https://openalex.org/W2049070044","https://openalex.org/W2052509184","https://openalex.org/W2061025681","https://openalex.org/W2074631079","https://openalex.org/W2092400503","https://openalex.org/W2128191648","https://openalex.org/W2144065980","https://openalex.org/W2190639287","https://openalex.org/W2290278229","https://openalex.org/W2399255518","https://openalex.org/W2413875973","https://openalex.org/W2413888254","https://openalex.org/W2419112193","https://openalex.org/W6637734684"],"related_works":["https://openalex.org/W2410816399","https://openalex.org/W2413888254","https://openalex.org/W2163398549","https://openalex.org/W2161927647","https://openalex.org/W2242618686","https://openalex.org/W2302958003","https://openalex.org/W2048904776","https://openalex.org/W2057992483","https://openalex.org/W2494286391","https://openalex.org/W2398108937"],"abstract_inverted_index":{"Abstract":[0],"A":[1],"new":[2],"antihistamine,":[3],"noberastine,":[4,262],"and":[5,14,21,31,53,60,85,136,144,149,155,164,184,199,212,219,225,244,264,270,281,289,295,347],"clinically":[6],"used":[7],"non\u2010sedating":[8,362],"antihistamines,":[9],"astemizole,":[10,348],"mequitazine,":[11,59],"terfenadine,":[12],"loratadine,":[13],"cetirizine":[15,271],"were":[16,63,138,214,266,306],"investigated":[17,189],"for":[18,54,93],"in":[19,28,103,125,160,308],"vitro":[20,161],"ex":[22,207],"vivo":[23,208],"binding":[24,76,109,115,163,209,336],"to":[25,177,252,325,355],"histamine\u2010H1":[26,41,178,186],"receptors":[27,42,187],"guinea\u2010pig":[29],"cerebellums":[30],"lungs.":[32],"In":[33,131],"vitro,":[34],"all":[35,174,278],"the":[36,72,88,96,98,122,197,215,254,304,309,312,319,334,339,357],"drugs":[37,198,305],"dissociated":[38],"slowly":[39],"from":[40],"(half\u2010times":[43],"\u2265":[44],"100":[45],"min),":[46],"Ki,app\u2010values":[47,62],"decreased":[48],"with":[49,65,152],"longer":[50],"incubation":[51,83],"times":[52,84,202],"potent":[55,141,217],"lipophilic":[56],"agents":[57],"(astemizole,":[58],"terfenadine)":[61],"lower":[64,157],"more":[66],"dilute":[67],"tissue":[68,91],"suspensions.":[69],"Because":[70],"of":[71,87,95,168,182,193,196,303,311,333,338,359],"slow":[73],"dissociation,":[74],"true":[75,113],"equilibrium":[77,114],"cannot":[78,117],"be":[79,118,356],"attained":[80],"during":[81],"limited":[82],"because":[86],"apparently":[89],"high":[90],"adsorption":[92],"some":[94],"drugs,":[97],"actual":[99],"free":[100],"drug":[101,204],"concentration":[102],"solution":[104],"is":[105,321],"unknown.":[106],"Therefore":[107],"measured":[108],"parameters":[110],"are":[111],"apparent;":[112],"constants":[116],"estimated.":[119],"Noberastine":[120,211],"showed":[121,220],"lowest":[123],"Ki,app\u2010value":[124],"various":[126,201],"assay":[127,133],"conditions":[128,134],"(0.55\u20130.15":[129],"nM).":[130,146],"optimized":[132],"astemizole":[135,213],"mequitazine":[137,243,263],"nearly":[139],"as":[140,342,349,361],"(Ki,app\u2010values":[142],"0.2":[143],"0.29":[145],"Terfenadine,":[147],"cetirizine,":[148],"loratidine":[150],"bound":[151,176],"30\u2010,":[153],"80\u2010":[154],"100\u2010times":[156],"affinity.":[158],"The":[159,180,300,327],"receptor":[162,227,234,240,283,292,298,335],"neurotransmitter":[165],"inhibition":[166],"profile":[167],"these":[169],"compounds":[170,358],"revealed":[171],"that":[172,316],"they":[173],"primarily":[175],"receptors.":[179],"occupation":[181,228,284],"lung":[183,224,233,280,291],"cerebellar":[185,226,239,282,297],"was":[188,250,258],"after":[190,203],"oral":[191],"administration":[192,205],"different":[194],"dosages":[195],"at":[200,277],"using":[206],"techniques.":[210],"most":[216],"componds":[218],"complete":[221],"differentiation":[222],"between":[223,279],"(with":[229],"0.63":[230],"mg.kg\u22121:":[231,287],"70%":[232,288,296],"occupancy,":[235],"less":[236],"than":[237],"10%":[238],"occupancy).":[241],"With":[242],"terfenadine":[245,265],"a":[246,330,343,350],"7\u2010times":[247],"higher":[248],"dose":[249],"required":[251],"reach":[253],"same":[255],"effect.":[256],"Astemizole":[257],"extremely":[259],"long":[260,351],"acting,":[261],"short":[267],"acting.":[268],"Loratidine":[269],"differentiated":[272],"very":[273],"poorly":[274],"or":[275],"not":[276,322],"(at":[285],"2.5":[286],"60%":[290],"occupation,":[293],"50%":[294],"occupation).":[299],"physicochemical":[301],"properties":[302,337],"considered":[307],"discussion":[310],"data.":[313],"It":[314],"appeared":[315,354],"penetration":[317],"into":[318],"brain":[320],"directly":[323],"related":[324],"lipophilicity.":[326],"study":[328],"allowed":[329],"quantitative":[331],"comparison":[332],"drugs.":[340],"Noberastine,":[341],"shorter":[344],"acting":[345,352],"agent,":[346,353],"choice":[360],"antihistamines.":[363]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}